Therapeutic interventions favorably influencing delayed and slow graft function in kidney transplantation: Mission impossible?

Transplantation

Volumn 85, Issue 7 SUPPL., 2008, Pages

  Peeters, Patrick ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Delayed graft function; Kidney; Slow graft function; Therapeutic intervention; Therapy; Transplantation

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTISENSE OLIGODEOXYNUCLEOTIDE; BASILIXIMAB; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CASPASE INHIBITOR; CYCLOSPORIN; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; ERDOSTEINE; GLIBENCLAMIDE; IMMUNOSUPPRESSIVE AGENT; MANNITOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN ANTIBODY; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TRIMETAZIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ATROPHY; BRAIN DEATH; CADAVER DONOR; CLINICAL TRIAL; DELAYED GRAFT FUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY DONOR; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STRESS; SURVIVAL RATE; TREATMENT OUTCOME;

BRAIN DEATH; DELAYED GRAFT FUNCTION; DONOR SELECTION; HUMANS; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; ORGAN PRESERVATION SOLUTIONS;

EID: 42049108475     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318169c548     Document Type: Review

References (42)

1. Halloran PF, Hunsicker LG. Delayed graft function: State of the art, November 10-11, 2000 summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001; 1: 115.
2. Rodrigo E, Ruiz JC, Pinera C, et al. Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant 2004; 4: 1163.
3. Humar A, Ramcharan T, Kandaswamy R, et al. Risk factors for slow graft function after kidney transplants: A multivariate analysis. Clin Transplant 2002; 16: 425.
4. Brier ME, Ray PC, Klein JB. Prediction of delayed renal allograft function using an artificial neural network. Nephrol Dial Transplant 2003; 18: 2655.
5. Boom H, Mallat MJ, de Fijter JW, et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859.
6. Irish WD, McCollum DA, Tesi RJ, et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003; 14: 2967.
7. Brennan TV, Freise CE, Fuller TF, et al. Early graft function after living donor kidney transplantation predicts rejection but not outcomes. Am J Transplant 2004; 4: 971.
8. Johnston TD, Thacker LR, Jeon H, et al. Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant 2004; 18(suppl 12): 28.
9. Oppenheimer F, Aljama P, Asensio PC, et al. The impact of donor age on the results of renal transplantation. Nephrol Dial Transplant 2004; 19(suppl 3): iii11.
10. Giessing M, Budde K, Fritsche L, et al. "Old-for-old" cadaveric renal transplantation: Surgical findings, perioperative complications and outcome. Eur Urol 2003; 44: 701.
11. Kruger B, Zulke C, Fischereder M, et al. Early experience with the ET senior program "Old For Old"; better to be number one? Transpl Int 2002; 15: 541.
12. Brook NR, White SA, Waller JR, et al. Non-heart beating donor kidneys with delayed graft function have superior graft survival compared with conventional heart-beating donor kidneys that develop delayed graft function. Am J Transplant 2003; 3: 614.
13. Cecka JM. Clinical Transplants. Los Angeles, UCLA Tissue Typing Laboratory 2002.
14. Roodnat JI, van Riemsdijk IC, Mulder PG, et al. The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: A single-center, multivariate analysis. Transplantation 2003; 75: 2014.
15. Pratschke J, Volk HD. "Brain death-associated ischemia and reperfusion injury." Curr Opin Organ Transplant 2004; 9: 153.
16. Nijboer WN, Schuurs TA, van der Hoeven JAB, et al. "Effect of brain death and donor treatment on organ inflammatory response and donor organ viability." Curr Opin Organ Transplant 2004; 9: 110.
17. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211.
18. Schramm L, La M, Heidbreder E, et al. L-Arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int 2002; 61: 1423.
19. Ponticelli C. Medical complications of kidney transplantation. Informa Healthcare UK Ltd. J Nutr 2007; 137: 1294.
20. Lynch R. Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin organ preservation solutions in kidney transplantation. Transpl Int 2007; 20: 338 [Abstract].
21. Wight JP, Chilcott JB, Holmes MW, et al. Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: A rapid and systematic review. Clin Transplant 2003; 17: 293.
22. Moers C. The European multicentre trial on kidney preservation: Results of a prospective randomised clinical study comparing post-transplant outcome after hypothermic machine perfusion versus simple cold storage in kidney transplantation. Transpl Int 2007; 20: 338 [Abstract].
23. Noreen HJ, McKinley DM, Gillingham KJ, et al. Positive remote cross-match: Impact on short-term and long-term outcome in cadaver renal transplantation. Transplantation 2003; 75: 501.
24. Arias M. Impact of the delayed graft function in hypersensitized kidney transplant patients. Transplant Proc 2003; 35: 1655.
25. Shilliday IR, Sherif M. Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients. Cochrane Database Syst Rev 2004: CD003421.
26. Boom H, Mallat MJ, de Fijter JW, et al. Calcium levels as a risk factor for delayed graft function. Transplantation 2004; 77: 868.
27. Lorenz M, Billensteiner E, Bodingbauer M, et al. The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function. Am J Kidney Dis 2004; 43: 1065.
28. McTaggart RA, Gottlieb D, Brooks J, et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003; 3: 416.
29. Gonwa T, Johnson C, Ahsan N, et al. Randomized trial of tacrolimus+ mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: Results at three years. Transplantation 2003; 75: 2048.
30. Heifets M, Saeed MI, Parikh MH, et al. Induction immunosuppression in kidney transplant recipients older than 60 years of age: Safety and efficacy of ATGAM, OKT3 and simulect. Drugs Aging 2004; 21: 747.
31. Goggins WC, Pascual MA, Powelson JA, et al. A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003; 76: 798.
32. Carlier M, Squifflet JP, Pirson Y, et al. Confirmation of the crucial role of the recipient's maximal hydration on early diuresis of the human cadaver renal allograft. Transplantation 1983; 36: 455.
33. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620.
34. Van Biesen W, Vanholder R, Van Loo A, et al. Peritoneal dialysis favorably influences early graft function after renal transplantation compared to hemodialysis. Transplantation 2000; 69: 508.
35. Vanholder R, Heering P, Loo AV, et al. Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared with hemodialysis. Am J Kidney Dis 1999; 33: 934.
36. Van Loo AA, Vanholder RC, Bernaert PR, et al. Pretransplantation hemodialysis strategy influences early renal graft function. J Am Soc Nephrol 1998; 9: 473.
37. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071.
38. Espejo B, Torres A, Valentin M, et al. Obesity favors surgical and infectious complications after renal transplantation. Transplant Proc 2003; 35: 1762.
39. Akalin E, Neylan JF. The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation 2003; 75: 1496.
40. McDaniel DO, Barber WH, Nguyan C, et al. Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients. Transpl Immunol 2003; 11: 107.
41. Kwon O, Molitoris BA, Pescovitz M, et al. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis 2003; 41: 1074.
42. Gill JS, Pereira BJ. Death in the first year after kidney transplantation: implications for patients on the transplant waiting list. Transplantation 2003; 75: 113.